What's breaking now, across thousands of outlets.
(RTTNews) - Nxera Pharma Co., Ltd. (4565.T), a technology-powered biopharmaceutical company, on Wednesday announced an exclusive licensing, supply and commercialization agreement with Synmosa Biopharma Corp. (4114.TWO).
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
European luxury goods firms have lost $350 billion in market value this year as hopes for sector recovery fade and weakness persists in China.
Major Gulf stock markets were mixed in early trade on Wednesday, with Saudi shares falling after an attack on a Saudi Aramco site heightened concerns over the escalating conflict between the kingdom…
United Overseas Bank’s (UOB) Quek Ser Leang and Lee Sue Ann report that GBP/USD has bounced firmly to 1.3255, invalidating their prior downside-bias call.
Taiwan has agreed to invest up to $4.4 billion in the Alaska LNG project and commit to buying 30% of its output over a period of 20 years, President Trump said, as quoted by AFP, during a campaign…
Apple faces significant uncertainty as a new CEO takes the helm.
